Literature DB >> 18032408

Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.

Lisa D Beilke1, David G Besselsen, Quiqiong Cheng, Supriya Kulkarni, Angela L Slitt, Nathan J Cherrington.   

Abstract

The multidrug resistance-associated proteins (Mrps) are a family of adenosine triphosphate-dependent transporters that facilitate the movement of various compounds, including bile acids, out of hepatocytes. The current study was conducted to determine whether induction of these transporters alters bile acid disposition as a means of hepatoprotection during bile acid-induced cholestasis. Lithocholic acid (LCA) was used to induce intrahepatic cholestasis. C57BL/6 mice were pretreated with corn oil (CO) or known transporter inducers, phenobarbital (PB), oltipraz (OPZ), or TCPOBOP (TC) for 3 days prior to cotreatment with LCA and inducer for 4 days. Histopathology revealed that PB and TC pretreatments provide a protective effect from LCA-induced toxicity, whereas OPZ pretreatment did not. Both PB/LCA and TC/LCA cotreatment groups also had significantly lower alanine aminotransferase values than the LCA-only group. In TC/LCA cotreated mice compared with LCA only, messenger RNA (mRNA) expression of uptake transporters Ntcp and Oatp4 was significantly increased, as were sinusoidal efflux transporters Mrp3 and Mrp4. Although in PB/LCA cotreated mice, the only significant change compared with LCA-only treatment was an increase in uptake transporter Oatp4. Oatp1 was reduced in all groups compared with CO controls. No significant changes in mRNA expression were observed in Oatp2, Bsep, Mrp2, Bcrp, Mrp1, Mrp5, or Mrp6. Mrp4 protein expression was induced in the OPZ/LCA and TC/LCA cotreated groups, whereas Mrp3 protein levels remained unchanged between groups. Protein expression of Mrp1 and Mrp5 was increased in the unprotected LCA-only and OPZ/LCA mice. Thus, transporter expression did not correlate with histologic hepatoprotection, however, there was a correlation between hepatoprotection and significantly reduced total liver bile acids in the PB/LCA and TC/LCA cotreated mice compared with LCA only. In conclusion, changes in transporter expression did not correlate with hepatoprotection, and therefore, transport may not play a critical role in the observed hepatoprotection from LCA-induced cholestasis in the C57BL/6 mouse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032408     DOI: 10.1093/toxsci/kfm287

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  10 in total

Review 1.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

2.  Role of breast cancer resistance protein in the adaptive response to cholestasis.

Authors:  Albert Mennone; Carol J Soroka; Kathy M Harry; James L Boyer
Journal:  Drug Metab Dispos       Date:  2010-07-02       Impact factor: 3.922

3.  Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.

Authors:  Qian Wang; Guo-Chao Song; Feng-Yi Weng; Bin Zou; Jing-Yi Jin; Dong-Ming Yan; Bo Tan; Jing Zhao; Yue Li; Fu-Rong Qiu
Journal:  Front Pharmacol       Date:  2022-05-31       Impact factor: 5.988

4.  Decreased apoptosis during CAR-mediated hepatoprotection against lithocholic acid-induced liver injury in mice.

Authors:  Lisa D Beilke; Lauren M Aleksunes; Erik R Olson; David G Besselsen; Curtis D Klaassen; Katerina Dvorak; Nathan J Cherrington
Journal:  Toxicol Lett       Date:  2009-03-20       Impact factor: 4.372

5.  Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice.

Authors:  Lisa D Beilke; Lauren M Aleksunes; Ricky D Holland; David G Besselsen; Rick D Beger; Curtis D Klaassen; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2009-02-05       Impact factor: 3.922

6.  Huqi San-Evoked Rat Colonic Anion Secretion through Increasing CFTR Expression.

Authors:  Xiaowei Xue; Zhengming Shi; Wen Wang; Xiaotong Yu; Ping Feng; Min Zhang; Xuejiang Wang; Jingdong Xu
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-28       Impact factor: 2.629

7.  The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium.

Authors:  Jayashree Sarathy; Sally Jo Detloff; Mei Ao; Nabihah Khan; Sydney French; Hafsa Sirajuddin; Tanushree Nair; Mrinalini C Rao
Journal:  Physiol Rep       Date:  2017-05

8.  Preventive effect of artemisinin extract against cholestasis induced via lithocholic acid exposure.

Authors:  Adel Qlayel Alkhedaide; Tamer Ahmed Ismail; Saad Hmoud Alotaibi; Mohamed Abdo Nassan; Zafer Saad Al Shehri
Journal:  Biosci Rep       Date:  2018-11-20       Impact factor: 3.840

9.  Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Petia Shipkova; Nelly Aranibar; Donald Robertson; Michael D Reily; Zhenqiang Lu; Lois D Lehman-McKeeman; Nathan J Cherrington
Journal:  Toxicol Appl Pharmacol       Date:  2013-02-04       Impact factor: 4.219

Review 10.  Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.

Authors:  Ji Youn Yoo; Sung Soo Kim
Journal:  Nutrients       Date:  2016-03-18       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.